Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_assertion type Assertion NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_head.
- NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_assertion description "[Azacitidine gives encouraging results in Ph-negative MPN having progressed to AML or MDS, but response duration is short, and consolidation treatments have to be evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_provenance.
- NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_assertion evidence source_evidence_literature NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_provenance.
- NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_assertion SIO_000772 20664061 NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_provenance.
- NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_assertion wasDerivedFrom befree-20150227 NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_provenance.
- NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_assertion wasGeneratedBy ECO_0000203 NP953881.RAWTZWxDdzOdXSMBJzUGnpERgQ1Vy5rlHkAmqWArsqupg130_provenance.